Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 28;10(3):383-385.
doi: 10.14218/JCTH.2022.00135. Epub 2022 May 12.

Unraveling the Dynamic Role of Microtubules in the HBV Life Cycle

Urania Georgopoulou  1 , John Koskinas  2
Affiliations
Editorial

Unraveling the Dynamic Role of Microtubules in the HBV Life Cycle

Urania Georgopoulou et al. J Clin Transl Hepatol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

JK has been an editorial board member of Journal of Clinical and Translational Hepatology since 2018. UG has no conflict of interests related to this publication.

Figures

Fig. 1
Fig. 1. Diagram of novel MT targeted therapeutics in HBV infection.
Numbers indicated putative drug targets. (1) MAP1S inhibition/silencing, (2) MAP1S-dependent acetylation of MTs, and (3) MAP1S dependent autophagy. Blue lines indicate induction. Red lines indicate uppression. A red X indicates inhibition or silencing of MAP1S. Orange/yellow stars represent acetylation of MTs. HBV complete virion is shown by hexagonal capsid with green HBsAg and HBV naked capsid is shown by a brown hexagon. HBV, Hepatitis B virus; MAPs, microtubule associated proteins; MTs, microtubules; HCC, hepatocellular carcinoma.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Chuang YC, Tsai KN, Ou JJ. Pathogenicity and virulence of Hepatitis B virus. Virulence. 2022;13(1):258–296. doi: 10.1080/21505594.2022.2028483. - DOI - PMC - PubMed
    1. Yardeni D, Ghany MG. Review article: hepatitis B-current and emerging therapies. Aliment Pharmacol Ther. 2022;55(7):805–819. doi: 10.1111/apt.16828. - DOI - PubMed
    1. Akhmanova A, Steinmetz MO. Control of microtubule organization and dynamics: two ends in the limelight. Nat Rev Mol Cell Biol. 2015;16(12):711–726. doi: 10.1038/nrm4084. - DOI - PubMed
    1. Xie R, Wang F, McKeehan WL, Liu L. Autophagy enhanced by microtubule- and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis. Cancer Res. 2011;71(24):7537–7546. doi: 10.1158/0008-5472.can-11-2170. - DOI - PMC - PubMed
    1. Lei Y, Xu X, Liu H, Chen L, Zhou H, Jiang J, et al. HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G1/S cycle. Autophagy. 2021;17(12):4423–4441. doi: 10.1080/15548627.2021.1917948. - DOI - PMC - PubMed

Publication types